[Reproducibility of exhaled nitric oxide (FENO) measurements in healthy subjects].

Katedra i Klinika Chorób Wewnetrznych, Pneumonologii i Alergologii A. M. w Warszawie.
Pneumonologia i alergologia polska: organ Polskiego Towarzystwa Ftyzjopneumonologicznego, Polskiego Towarzystwa Alergologicznego, i Instytutu Gruzlicy i Chorob Pluc 02/2004; 72(9-10):395-9.
Source: PubMed


The aim of the study was to evaluate the short-term variability of FENO in healthy subjects.
33 healthy volunteers (26 F, 7 M) aged 32.6 +/- 9.5 yrs with body mass index (BMI) of 23.3 +/- 3 kg/m2 participated in the study. Exhaled nitric oxide was analyzed on 5 consecutive days with a chemiluminescence analyzer (NIOX, Aerocrine, Sweden) according to the ATS recommendations. The exhalation flow was between 0.045 and 0.055 l/s. The measurements were performed at the same time of the day and the subjects were asked to refrain from eating and drinking for at least one hour before the analysis.
The mean value of FENO for the whole group was 13.9 +/- 5.4 ppb, there were no correlations between FENO and age, BMI, sex or the concentration of ambient nitric oxide. Day-to-day coefficient of variation was 13.3 +/- 5.3% (range 4.6 - 23.9%), the value of pooled SD - 2.1 ppb and ICC (intraclass correlation coefficient) was 0.84. No relationship was observed between variability of FENO and intervals between measurement of exhaled nitric oxide and intake of food or beverages.
Chemiluminescence analysis of FENO with NIOX is a highly reproducible method, however one has to take into account the possibility of about 13% variability of FENO within 5 days.

7 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nitric oxide is a gas detectable in exhaled breath of humans and is recognized as a useful biomarker for asthma diagnosis and monitoring. Several studies have shown evidence of higher levels of exhaled nitric oxide in patients with respiratory diseases as compared with the healthy population. The possibility of using exhaled nitric oxide measurement as a tool for diagnosing and monitoring occupational exposures to allergic or toxic irritants is reviewed and discussed.
    Critical Reviews in Environmental Science and Technology 10/2011; 41(20-20):1820-1842. DOI:10.1080/10643389.2010.495636 · 3.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose of the research: The aim of this present study is examine the airway inflammation using the fractional exhaled nitric oxide (FeNO), to detect differences in FeNO measurements in comparison with spirometry and evaluate the use of this technique in health surveillance programs, also in order to determine the suitability to the specific task. What was done: Between November 2009 and February 2010 we recruited 74 volunteers, all professional divers from the Italian National Fire Services Department. A clinical-medical history questionnaire was administered, with guidance; then the study protocol was applied. Spirometry was conducted to measure respiratory function, and FeNO was assayed. What was found: Neither age nor body mass index (BMI) influenced FeNO, but there were significant differences related to smoking, particularly among ex-smokers (p < 0.05). A FeNO value higher than the threshold of 35 ppb was related to the spirometry results and questionnaire answers. What was concluded: This non-invasive method is useful in checking for respiratory disease; divers with high FeNO should be scheduled for further clinical-instrumental investigation and laboratory tests to make sure they have no diving contraindications.
    Undersea & hyperbaric medicine: journal of the Undersea and Hyperbaric Medical Society, Inc 09/2012; 39(5):901-7. · 0.77 Impact Factor